Advertisement

Lipid-Lowering Agents

  • Scott D. Friedman
  • Brian McClure
Chapter

Abstract

One of the most important jobs as an anesthesiologist is to reduce the incidence of adverse perioperative outcome and reduce the incidence of morbidity and mortality associated with various surgeries. Historically, this has been done through applying various medical therapies perioperatively and even postoperatively. Searching for the best therapies is a constant, ongoing pursuit to better the field of anesthesiology. Two huge examples of this ongoing pursuit to find medical therapies to reduce morbidity and mortality in the perioperative period include the use of pre-incision prophylactic antibiotics and perioperative beta-blockade. Another huge modality that is gaining interest is the use of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, also known as statins, as well as other lipid-lowering drugs.

Keywords

Statin Therapy Bile Acid Sequestrant Cholesterol Absorption Inhibitor Bind Bile Acid National Cholesterol Education Program Expert 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

The editors and publisher would like to thank Drs. Alan Kaye and Phillip Kalarickal for contributing to the chapter on this topic in the prior edition. It has served as the foundation for the chapter.

References

  1. 1.
    Mahley RW, Bersot TP. Chapter 35: Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman’s The pharmacological basis of therapeutics, 11th ed. New York: McGraw-Hill; 2006.Google Scholar
  2. 2.
    Aguila-Salinas CA, Barrett H, Schonfeld G. Metabolic modes of action of the statins in the hyperlipoproteinemias. Atherosclerosis. 1998;141:203–7.CrossRefGoogle Scholar
  3. 3.
    Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. 11th ed. New York: McGraw-Hill companies; 2009.Google Scholar
  4. 4.
    Biccard BM. A peri-operative statin update for non-cardiac surgery. Part I: the effects of statin therapy on atherosclerotic disease and lessons learnt from statin therapy in medical (non-surgical) patients. Anaesthesia. 2008;63:52–64.PubMedCrossRefGoogle Scholar
  5. 5.
    Williams D, Feely J. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors. Clin Pharmacokinet. 2002;41(5):343–70.PubMedCrossRefGoogle Scholar
  6. 6.
    Gajendragadkar PR, Cooper DG, Walsh SR, et al. Novel uses for statins in surgical patients. Intl J Surg. 2009;7:285–90.CrossRefGoogle Scholar
  7. 7.
    Williams TM, Harken AH. Statins for surgical patients. Ann Surg. 2008;247:30–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Rosenson RS, Tagney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA. 1998;279:1643–50.PubMedCrossRefGoogle Scholar
  9. 9.
    Cohen MC, Artz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovasc Pathol. 1999;8:133–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Dawood MM, Gupta DK, Southern J, et al. Pathology of fatal perioperative myocardial infarction; implications regarding pathophysiology and prevention. Intl J Cardiol. 1996;57:37–44.CrossRefGoogle Scholar
  11. 11.
    Li JJ, Li YS, Chen J, et al. Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy. Med Hypotheses. 2006;66:1199–204.PubMedCrossRefGoogle Scholar
  12. 12.
    Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMG-CoA reductase inhibitors. Basic Res Cardiol. 2002;97:105–16.PubMedCrossRefGoogle Scholar
  13. 13.
    Wolfrum S, Jensen KS, Liao JK. Endothelium-dependent effects of statins. Arterioscler ThrombVasc Biol. 2003;23:729–36.CrossRefGoogle Scholar
  14. 14.
    Manach YL, et al. Statin therapy within the perioperative period. Anesthesiology. 2008;108:1141–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Rossi S, editor. Australian medicines handbook 2006. Adelaide: Australian Medicines Handbook; 2006.Google Scholar
  16. 16.
    Armitage J. The safety of statins in clinical practice. Lancet. 2007;370:1781–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Calderon RM, et al. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clin Proc. 2010;85:349–56.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Ballantyne CM, Corsini A, Davidson MH, et al. Risk for myopathy with statin therapy in high-risk patients. Arch Intern Med. 2003;163:553–64.PubMedCrossRefGoogle Scholar
  19. 19.
    Black DM. A general assessment of the safety of HMG CoA reductase inhibitors (statins). Curr Artheroscler Rep. 2002;4:34–41.CrossRefGoogle Scholar
  20. 20.
    Ridker PM, Danielson E, Fonseca FA, JUPITER Study Group, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–207.PubMedCrossRefGoogle Scholar
  21. 21.
    Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735–42.PubMedCrossRefGoogle Scholar
  22. 22.
    Corsini A, Bellosta S, Baetta R, et al. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol. Ther. 1999;84:413–28.PubMedCrossRefGoogle Scholar
  23. 23.
    Schouten O, Hoeks SE, Welten G, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007;100:316–20.PubMedCrossRefGoogle Scholar
  24. 24.
    American College of Cardiology/American Heart Association/National Heart Lung Blood Institute. Clinical advisory on the use and safety of Statins. J Am Coll Cardiol. 2002;40:567–72.CrossRefGoogle Scholar
  25. 25.
    Schouten O, Kertai MD, Bax JJ, et al. Safety of perioperative statin use in high-risk patients undergoing vascular surgery. Am J Cardiol. 2005;95:658–60.PubMedCrossRefGoogle Scholar
  26. 26.
    Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.Google Scholar
  27. 27.
    Grundy SM, Cleeman JL, Merz CN, et al. Implications of recent trials for the national cholesterol education program adult treatment Panel III guidelines. Circulation. 2004;110:227–39.PubMedCrossRefGoogle Scholar
  28. 28.
    Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. A report of the American college of cardiology/American heart association task force on practice guidelines. Circulation. 2007;116:e418–99.PubMedCrossRefGoogle Scholar
  29. 29.
    Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, French WJ. Effect of stain use within the first 24 hours of administration for acute myocardial infarction on early morbidity and mortality. Am J Cardiol. 2005;96:611–6.PubMedCrossRefGoogle Scholar
  30. 30.
    National Confidential Enquiry into Patient Outcome and Death. Report-abdominal aortic aneurysm: a service in need of surgery? London: NCEPOD; 2005. http://www.ncepod.org.uk/2005report2/Downloads/AAA_report.doc2005.
  31. 31.
    Conte MS, Bandyk DF, Clowes AW, et al. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg. 2005;42:829–36; discussion 836–7.CrossRefGoogle Scholar
  32. 32.
    Bicard BM. A peri-operative statin update for non-cardiac surgery. Part II: statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia. 2008;63:162–71.CrossRefGoogle Scholar
  33. 33.
    American Heart Association. Cardiovascular disease statistics. 2006. Available at: http://www.americanheart.org/presenter.jhtml?identifier=4478.
  34. 34.
    British Heart Foundation statistics website. CVD mortality in Europe. 2005. Available at: http://www.heartstats.org/topic.asp?id=753.

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of AnesthesiologyTulane University School of MedicineNew OrleansUSA

Personalised recommendations